115 related articles for article (PubMed ID: 4678455)
1. [Incidence of L.A.T.S. demonstration in untreated recent hyperthyroidism. Comparison of 2 continuous series].
Mornex R; Massin JP; Orgiazzi J; Savoie JC
Ann Endocrinol (Paris); 1972; 33(2):177-84. PubMed ID: 4678455
[No Abstract] [Full Text] [Related]
2. L.A.T.S. and Graves' disease.
Hedley AJ; Ross IP; Crooks J
Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
[No Abstract] [Full Text] [Related]
3. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
Onaya T; Kotani M; Yamada T; Ochi Y
J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
[No Abstract] [Full Text] [Related]
4. [Biological determination of thyrotropin and long-acting thyroid simulator].
Potin VV; Stepanov GS
Probl Endokrinol (Mosk); 1969; 15(4):64-7. PubMed ID: 5395630
[No Abstract] [Full Text] [Related]
5. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
6. [Significance of the "long acting thyroid stimulator"].
Tourneur R; Letonturier P; Sénécal P
Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
[No Abstract] [Full Text] [Related]
7. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
8. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
9. 35-S-sulfate uptake by mouse harderian gland: effect of serum from patients with Graves' disease.
Singh SP; McKenzie JM
Metabolism; 1971 Apr; 20(4):422-7. PubMed ID: 5107990
[No Abstract] [Full Text] [Related]
10. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
11. Placental transmission of thyroid-stimulating immunoglobulins.
Dirmikis SM; Munro DS
Br Med J; 1975 Jun; 2(5972):665-6. PubMed ID: 1173561
[TBL] [Abstract][Full Text] [Related]
12. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
13. [Concentration of plasma in hyperthyroid patients for the detection of G immunoglobulins with LATS activity].
Orgiazzi J; Rousset B; Mornex R
Ann Endocrinol (Paris); 1972; 33(2):139-47. PubMed ID: 4678454
[No Abstract] [Full Text] [Related]
14. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
15. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
Lamberg BA; Gordin A; Viherkoski M; Kvist G
Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
[No Abstract] [Full Text] [Related]
16. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
Tourneur R; Letonturier P; Sénécal P
Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
[No Abstract] [Full Text] [Related]
17. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
18. The clinical significance of plasma thyroid-stimulating ctivity in hyperthyroidism.
Hoffmann MJ; Hetzel BS
Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4169740
[No Abstract] [Full Text] [Related]
19. The clinical significance of plasma thyroid-stimulating activity in hyperthyroidism.
Hoffmann MJ; Hetzel BS
Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4168752
[No Abstract] [Full Text] [Related]
20. The value of IgG separation for the detection of LATS in human serum.
Bonnyns M; Vanhaelst L
Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
